PharmaLegacy Laboratories (Shanghai) Co., Ltdhas a group of high-quality, experienced, responsibility, in particular actual combat experience professionals of PDX Modelx2a38631n. Our customers all over the country and overseas ,with its unique geographical advantage and comprehensive diversified information channels, Our companys main business scope : Pharmacodynamic evaluation test platform,humanized animal model,antibody research and development servi and so on.

   PharmaLegacy Laboratories (Shanghai) Co., Ltd is committed to innovation and apply of PDX Model, and strive to create a more high-quality industry service. And in this tremendous task , PharmaLegacysincerely welcome customers and partners with us join hands with the progress, create brilliant. details:

   PharmaLegacy Laboratories (Shanghai) Co., Ltd and PDX Model,Humanized mouse modelhave enjoyed great popularity and trust by the majority of customers. We dedicate to strict implementation of quality management system and practical effort on quality control. To set up an idea of quality as foundation, credibility of reputation, customer first , we forge ahead and relentlessly pursuit of quality improvement. For more information, please visit the official website: www.pharmalegacy.com

PharmaLegacy Laboratories is a leading speciality pharmacology Contract Research Organization located in Shanghai Zhangjiang High-Tech Park, China. PharmaLegacy is equipped with a world-class facility, working to international pharmaceutical industrial standards. PharmaLegacy provides preclinical in vivo pharmacology efficacy services as well a therapeutic antibody discovery service program. Our state-of-the-art platforms include:· Pioneering work using CD34+ humanized mice that carry a human immune system, to test biologics for immuno-oncology therapeutic efficacy· An NHP platform for therapeutic biologics testing in a variety of immune diseases · An advanced antibody discovery platform based on single B cell antibody sequencing · An internationally recognized Bone/Orthopaedics platform to test both hard tissue disease therapeutic candidates and medical devicesPharmaLegacy offers a full range of preclinical pharmacology services for evaluating pharmacological effects of drug candidates in the areas of inflammation/auto-Immune diseases, lung injury, liver/metabolic diseases and oncology. Our NHP platform and CD34+ humanized mice models have helped dozens of clients with IND filings